| mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |